Israel Englander Volitionrx LTD Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.36 - $2.38 $25,976 - $45,458	-19,100 Reduced 43.82%	24,486 $33,000
Q2 2022 Aug 15, 2022	SELL	$1.96 - $3.05 $25,826 - $40,189	-13,177 Reduced 23.21%	43,586 $89,000
Q1 2022 May 16, 2022	SELL	$2.41 - $3.24 $14,120 - $18,983	-5,859 Reduced 9.36%	56,763 $171,000
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $2,159 - $2,952	-715 Reduced 1.13%	62,622 $197,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $3.48 $631,429 - $737,373	-211,889 Reduced 76.99%	63,337 $196,000
Q2 2021 Aug 16, 2021	BUY	$3.01 - $3.78 $774,244 - $972,306	257,224 Added 1428.86%	275,226 $905,000
Q1 2021 May 17, 2021	BUY	$3.33 - $6.5 $59,946 - $117,013	18,002 New	18,002 $68,000
Q2 2020 Aug 14, 2020	SELL	$2.89 - $4.32 $422,260 - $631,199	-146,111 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$2.47 - $5.16 $360,894 - $753,932	146,111 New	146,111 $454,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $39M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.